Making early cerebral palsy screening more accessible

Exploring new ways to identify babies at risk of cerebral palsy sooner and support better outcomes.

Making early cerebral palsy screening more accessible

July 1, 2026
Exploring new ways to identify babies at risk of cerebral palsy sooner and support better outcomes.
Read Transcript

The challenge

Cerebral palsy (CP) is the most common childhood-onset physical disability, affecting around 1 in 700 children born in Australia. Early diagnosis is critical, as the first months of life are a crucial period for brain development, and early intervention can improve long-term outcomes for children with CP.

Despite reliable screening tools being available, only around 30% of infants who will go on to receive a CP diagnosis are currently screened. This means many children miss the opportunity for early identification and intervention.

The General Movements Assessment (GMA) is a reliable tool for identifying babies who may be at higher risk of CP. However, limited numbers of trained assessors make it difficult to offer screening more widely. The Early General Movements Screening Feasibility Pilot is testing whether training additional assessors can help expand access to screening.

“Families should not need luck, persistence or privilege to find answers. A national screening system would help ensure they no longer do.”

Parent partner involved in the project

The research

Led by Cerebral Palsy Alliance researchers Dr Catherine Morgan, Dr Cathryn Crowle and Dr Michelle Jackman, the pilot is investigating whether newly trained assessors can complete the GMA as accurately as experienced assessors. Families are invited to record videos of their babies using the Baby Moves smartphone app, which are assessed by both newly trained and experienced assessors. Early results are encouraging, with 89% agreement between assessors, showing the potential of trained assessors to help expand access to early CP screening.

Early impact

Funding from Hearts & Minds has enabled a dedicated project coordinator and research nurses at participating hospitals to manage the study, engage families, and support infant screening across each site. This has helped ensure the pilot can be delivered effectively and families are supported throughout the screening process.

Already, 5 of the 142 babies who would not otherwise have received general movements screening have been identified as requiring follow-up, highlighting the benefit of expanding access to earlier screening.

The pilot has also helped secure additional government funding to advance universal screening using machine learning, with data from this study contributing to future research. If successful, this research could pave the way for universal CP screening across Australia, enabling more babies to receive earlier diagnosis, earlier intervention, and better long-term outcomes.

Funding support from Hearts & Minds. This content was last updated in July 2026. For further information, visit Cerebral Palsy Alliance.

The challenge

Cerebral palsy (CP) is the most common childhood-onset physical disability, affecting around 1 in 700 children born in Australia. Early diagnosis is critical, as the first months of life are a crucial period for brain development, and early intervention can improve long-term outcomes for children with CP.

Despite reliable screening tools being available, only around 30% of infants who will go on to receive a CP diagnosis are currently screened. This means many children miss the opportunity for early identification and intervention.

The General Movements Assessment (GMA) is a reliable tool for identifying babies who may be at higher risk of CP. However, limited numbers of trained assessors make it difficult to offer screening more widely. The Early General Movements Screening Feasibility Pilot is testing whether training additional assessors can help expand access to screening.

“Families should not need luck, persistence or privilege to find answers. A national screening system would help ensure they no longer do.”

Parent partner involved in the project

The research

Led by Cerebral Palsy Alliance researchers Dr Catherine Morgan, Dr Cathryn Crowle and Dr Michelle Jackman, the pilot is investigating whether newly trained assessors can complete the GMA as accurately as experienced assessors. Families are invited to record videos of their babies using the Baby Moves smartphone app, which are assessed by both newly trained and experienced assessors. Early results are encouraging, with 89% agreement between assessors, showing the potential of trained assessors to help expand access to early CP screening.

Early impact

Funding from Hearts & Minds has enabled a dedicated project coordinator and research nurses at participating hospitals to manage the study, engage families, and support infant screening across each site. This has helped ensure the pilot can be delivered effectively and families are supported throughout the screening process.

Already, 5 of the 142 babies who would not otherwise have received general movements screening have been identified as requiring follow-up, highlighting the benefit of expanding access to earlier screening.

The pilot has also helped secure additional government funding to advance universal screening using machine learning, with data from this study contributing to future research. If successful, this research could pave the way for universal CP screening across Australia, enabling more babies to receive earlier diagnosis, earlier intervention, and better long-term outcomes.

Funding support from Hearts & Minds. This content was last updated in July 2026. For further information, visit Cerebral Palsy Alliance.

Disclaimer: This material has been prepared by Hearts & Minds, published on July 1, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Picture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt Call
July 1, 2026

Next generation CAR T-cell therapy for cancer

The Call Lab at WEHI is pioneering innovative approaches to find this ‘goldilocks zone’, making CAR T-cell therapy safer and more effective.

Read More
Picture: Associate Professor Neale CohenPicture: Associate Professor Neale CohenPicture: Associate Professor Neale CohenPicture: Associate Professor Neale Cohen
July 1, 2026

Revolutionising Diabetes Care

Improving diabetes care has the potential to transform individual health outcomes while strengthening the wellbeing of entire communities.

Read More
HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).
May 4, 2026

How science turned back the clock of human development to create a miracle blood stem cell

Many thought it could never be done. But three Murdoch Children’s Research Institute scientists recreated embryonic development to crack the blood stem cell code.

Read More
November 15, 2024

Professor Alex Brown in conversation with Professor Jason Kovacic

At the 2024 Sohn Hearts & Minds Conference, we heard from Professor Alex Brown in conversation with Professor Jason Kovacic about Indigenous heart health and genomics.

Read More

A/Professor Tim Sargeant | 2024 Sohn Hearts & Minds Conference

Associate Professor Tim Sargeant has been at SAHMRI (South Australian Health and Medical Research Institute) in Adelaide where he studies the role of lysosomes in Alzheimer’s disease.

Read More
July 1, 2026

Unlocking the mysteries of the human brain

The Sydney Brain Bank is helping researchers uncover the causes of neurodegenerative disease and build a future with better diagnosis, treatment and prevention.

Read More
Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.
July 1, 2026

A new approach to Parkinson’s Disease

Exploring nerve stimulation as a potential treatment.

Read More
Dr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds Conference
July 1, 2026

Revealing what drives PSP

Mapping the biological changes behind progressive supranuclear palsy in the brain.

Read More
Picture: Dr Jennifer SnaithPicture: Dr Jennifer SnaithPicture: Dr Jennifer SnaithPicture: Dr Jennifer Snaith
July 1, 2026

Advancing treatment options for type 1 diabetes

Improving blood glucose and reducing insulin needs.

Read More
Picture: Dr Hamish KingPicture: Dr Hamish KingPicture: Dr Hamish KingPicture: Dr Hamish King
July 1, 2026

Solving the genetic causes of autoimmune diseases

Mapping hundreds of risk markers to better understand how these diseases develop and progress

Read More
July 1, 2026

The Future of Pain Management

Enhancing healthcare professionals' ability to deliver better pain management, now and into the future.

Read More
July 1, 2026

Harnessing the power of stem cell technology

Developing cell therapies for patients with blood diseases

Read More
Picture: Professor Kazuaki NegishiPicture: Professor Kazuaki NegishiPicture: Professor Kazuaki NegishiPicture: Professor Kazuaki Negishi
July 1, 2026

Protecting the heart when every minute matters

Investigating a new treatment to reduce heart damage after heart attacks

Read More
Picture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio Vittorio
July 1, 2026

Targeting the drivers of cancer growth

Exploring how extrachromosomal DNA (ecDNA) drives cancer growth, spread and treatment resistance.

Read More
July 1, 2026

Improving the diagnosis of muscle disorders using advanced genetic testing

Focused on improving the efficiency and accuracy of diagnosing muscle disorders.

Read More